Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
A powerful strategy for treating type 2 diabetes is combination therapy with basal insulin and semaglutide to harness their different mechanisms and target the various tissues involved in glucose regulation
Who Might Tolerate One Better Than the Other Choosing between AOD-9604 and MOTS-c based on side-effect profile requires weighing incomplete data against individual risk factors
It represents a novel therapeutic class as the first dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist
Your SheMed clinician can review your progress and confirm whether maintaining your current dose is the right approach
Rational truncation of an RNA aptamer to prostate-specific membrane antigen using computational structural modeling
March 20, 2015
US$ 27.34
US$ 29.84
US$ 20.64
US$ 22.32
US$ 21.86
US$ 21.38
US$ 21.76
US$ 22.17
US$ 22.57
